TWEAK increases angiogenesis to promote diabetic skin wound healing by regulating Fn14/ EGFR signaling
Journal of Cosmetic Dermatology · 2024
DOI: 10.1111/jocd.16486 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2024. Verfasst von Ying-Jie Zhu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Wound Healing, Cytokine TWEAK, TWEAK Receptor, ErbB Receptors. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Southern University of Science and Technology Hospital Director's Research Fund.
Themen: Wundversorgung
Abstract (Originalsprache)
Objective
Tumor necrosis factor‐like weak inducer of apoptosis (TWEAK), a member of tumor necrosis factor superfamily, can bind to fibroblast growth factor‐inducible 14 (Fn14) receptor and stimulate angiogenesis. The interaction between epidermal growth factor receptor (EGFR) and endothelial growth factor (EGF) leads to EGFR signal transduction and promotes angiogenesis. The objective of this study was to explore whether TWEAK participated in the diabetic skin wound healing by regulating Fn14/EGFR signaling.
Methods
Human umbilical vein endothelial cells (HUVECs) were treated with 35 mmol/L d ‐glucose and classified into the Control Group, High Glucose (HG) Group and HG + TWEAK Group. Then, the TWEAK expression and the proliferation, migration and tubule formation of HUVECs were detected, respectively. In vivo experiment, the diabetic model was established by injecting streptozotocin (STZ, 50 mg/kg) into male BALB/c mice. On the back of successfully modeled diabetic mice, a full‐thickness skin wound of 6 mm diameter was formed. Then, the mice were randomly assigned into three groups: Blank Group, Phosphate Buffer Saline (PBS) Group, and TWEAK Group. Subsequently, expression levels of TWEAK, Fn14, EGFR and vascular endothelial growth factor (VEGF)‐A were measured, and the CD31 expression in the wounded skin tissue of mice was checked by immunohistochemistry staining.
Results
The expression level of TWEAK in HUVECs of HG Group decreased significantly, as well as the viability, migration, and tubule formation of cells. After over‐expression of TWEAK, the cell viability, migration, and tubule formation abilities of HUVECs recovered remarkably. In vivo, the wound healing rate of diabetic mice was raised, the neovascularization was increased, and the CD31 expression in the wounded tissue was obviously upregulated after injection with recombinant TWEAK antibody.
Conclusion
TWEAK stimulates angiogenesis and accelerates the wound healing of diabetic skin by regulating Fn14/EGFR signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Southern University of Science and Technology Hospital, Shenzhen, Guangdong, China.
- Department of Dermatology, Guangdong Women and Children Hospital, Guangzhou, Guangdong, China.
Förderung
- Southern University of Science and Technology Hospital Director's Research Fund
Zitieren
APA
Zhu, Y. J., Chen, H. L., Huang, J. K., Cai, X. J., & Zhan, B. L. (2024). TWEAK increases angiogenesis to promote diabetic skin wound healing by regulating Fn14/ EGFR signaling. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.16486
Vancouver
Zhu YJ, Chen HL, Huang JK, Cai XJ, Zhan BL. TWEAK increases angiogenesis to promote diabetic skin wound healing by regulating Fn14/ EGFR signaling. Journal of Cosmetic Dermatology. 2024. doi:10.1111/jocd.16486
BibTeX
@article{Zhu2024,
author = {Zhu, Ying-Jie and Chen, Hu-Lin and Huang, Jing-Kai and Cai, Xin-Jie and Zhan, Bang-le},
title = {TWEAK increases angiogenesis to promote diabetic skin wound healing by regulating Fn14/ EGFR signaling},
journal = {Journal of Cosmetic Dermatology},
year = {2024},
doi = {10.1111/jocd.16486}
}
EUVIMED